Detection of Pandemic (H1N1) 2009 Virus in Patients Treated with Oseltamivir
نویسندگان
چکیده
1. Alexander DJ, Brown IH. History of highly pathogenic avian infl uenza. Rev Sci Tech. 2009;28:19–38. 2. Chen H, Smith GJ, Zhang SY, Qin K, Wang J, Li KS, et al. H5N1 virus outbreak in migratory waterfowl. Nature. 2005;436:191–2. DOI: 10.1038/nature03974 3. Lipatov AS, Evseenko VA, Yen HL, Zaykovskaya AV, Durimanov AG, Zolotykh SI, et al. Infl uenza (H5N1) viruses in poultry, Russian Federation, 2005–2006. Emerg Infect Dis. 2007;13:539–46. DOI: 10.3201/eid1304.061266 4. World Organisation for Animal Health. Avian infl uenza [cited 2009 Jun 1]. http:// www.oie.int/eng/info_ev/en_AI_factoids_H5N1_Timeline.htm 5. Keawcharoen J, van Riel D, van Amerongen G, Bestebroer T, Beyer WE, van Lavieren R, et al. Wild ducks as longdistance vectors of highly pathogenic avian infl uenza virus (H5N1). Emerg Infect Dis. 2008;14:600–7. DOI: 10.3201/ eid1404.071016 6. Evseenko VA, Bukin EK, Zaykovskaya AV, Sharshov KA, Ternovoi VA, Ignatyev GM, et al. Experimental infection of H5N1 HPAI in BALB/c mice. Virol J. 2007;4:77. DOI: 10.1186/1743-422X-4-77 7. L’vov DK, Zhchelkanov MIu, Vlasov NA, Prilipov AG, Deriabin PG, Fediakina IT et al. The fi rst break-through of the genotype 2.3.2 of high-virulence infl uenza A virus A/HSN1, which is new for Russia, in the Far East [in Russian]. Vopr Virusol. 2008;53:4–8. 8. Spackman E, Senne DA, Myers TJ, Bulaga LL, Garber LP, Perdue ML, et al. Development of a real-time reverse transcriptase PCR assay for type A infl uenza virus and the avian H5 and H7 hemagglutinin subtypes. J Clin Microbiol. 2002;40:3256–60. DOI: 10.1128/JCM.40.9.3256-3260.2002 9. Tamura K, Dudley J, Nei M, Kumar S. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol. 2007;24:1596–9. DOI: 10.1093/molbev/msm092 Address for correspondence: Kirill Sharshov, State Research Center of Virology and Biotechnology (VECTOR), Koltsovo, Novosibirsk Region, 630559 Russia; email: [email protected]
منابع مشابه
Characterization of Oseltamivir-Resistant 2009 H1N1 Pandemic Influenza A Viruses
Influenza viruses resistant to antiviral drugs emerge frequently. Not surprisingly, the widespread treatment in many countries of patients infected with 2009 pandemic influenza A (H1N1) viruses with the neuraminidase (NA) inhibitors oseltamivir and zanamivir has led to the emergence of pandemic strains resistant to these drugs. Sporadic cases of pandemic influenza have been associated with muta...
متن کاملOseltamivir-Resistant Pandemic (H1N1) 2009 Virus, Mexico
During May 2009-April 2010, we analyzed 692 samples of pandemic (H1N1) 2009 virus from patients in Mexico. We detected the H275Y substitution of the neuraminidase gene in a specimen from an infant with pandemic (H1N1) 2009 who was treated with oseltamivir. This virus was susceptible to zanamivir and resistant to adamantanes and oseltamivir.
متن کاملDetection of Seasonal Influenza H1N1 and H3N2 Viruses using RT-PCR Assay during 2009 Flu Pandemic in Golestan Province
Abstract Background and Objective: The emergence of a novel H1N1influenza A virus of animal origin with transmissibility from human to human poses pandemic concern. Current subtypes of Seasonal influenza A viruses spread in human are influenza A H1N1 influenza A H3N2 and influenza type B viruses. The aim of this study was to determine current strains of the H3N2 and new H1N1 subtypes of influe...
متن کاملMonitoring and Characterization of Oseltamivir-Resistant Pandemic (H1N1) 2009 Virus, Japan, 2009–2010
To monitor and characterize oseltamivir-resistant (OR) pandemic (H1N1) 2009 virus with the H275Y mutation, we analyzed 4,307 clinical specimens from Japan by neuraminidase (NA) sequencing or inhibition assay; 61 OR pandemic (H1N1) 2009 viruses were detected. NA inhibition assay and M2 sequencing indicated that OR pandemic (H1N1) 2009 virus was resistant to M2 inhibitors, but sensitive to zanami...
متن کاملH275Y Mutant Pandemic (H1N1) 2009 Virus in Immunocompromised Patients
Most oseltamivir-resistant pandemic (H1N1) 2009 viruses have been isolated from immunocompromised patients. To describe the clinical features, treatment, outcomes, and virologic data associated with infection from pandemic (H1N1) 2009 virus with H275Y mutation in immunocompromised patients, we retrospectively identified 49 hematology-oncology patients infected with pandemic (H1N1) 2009 virus. S...
متن کاملVirological clearance rate of high-dose oseltamivir or triple-combination antiviral therapy in complicated 2009 pandemic influenza A (H1N1) infection.
The 2009 pandemic influenza A (H1N1) was a considerable public health concern worldwide. Significant morbidity and mortality were observed in complicated cases, despite the early administration of neuramidase inhibitors. The limitations of neuramidase inhibitor monotherapy have renewed interest in combination antiviral therapy or higher-dose oseltamivir therapy. Herein, we report our clinical e...
متن کامل